Patent intelligence · US
US 7348429
Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon access…
Patent details — US 7348429
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 25, 2008
- Expiration
- Mar 20, 2028
- Claims
- 2
- CPC classes
- A61P, A61P25/20
Quick answer
US 7348429 (Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process) is held by TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság. Status: granted. Granted Mar 25, 2008. Expires Mar 20, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 2
- CPC classes
- A61P, A61P25/20
More from TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság
Related pharmaceutical patents in our USPTO index.
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12139528
Treating refractory migraine
granted -
US 12091388
Solid state forms of Reproxalap
granted -
US 11826322
Pre-filled syringe
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11773083
Solid state forms of Belumosudil and Belumosudil salts
granted
Frequently asked questions
What is US patent 7348429?
US 7348429 (Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process) is held by TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság. Status: granted. Granted Mar 25, 2008. Expires Mar 20, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7348429?
TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.
When does US 7348429 expire?
Our index shows an expiration date of Mar 20, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.